• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Clovis Oncology Inc

+ Add to Watchlist


40.137 EUR 1.000 2.43%

As of 11:03:22 ET on 04/17/2014.

Snapshot for Clovis Oncology Inc (C6O)

Open: 40.060 Day's Range: 39.825 - 40.137 Volume: 10
Previous Close: 41.137 52wk Range: 24.009 - 66.162 1-Yr Rtn: +67.33%

Stock Chart for C6O

No chart data available.
  • C6O:GR 40.137
  • 1D
  • 1M
  • 1Y
Interactive C6O Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for C6O

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -3.8770
Est. PEG Ratio -
Market Cap (M EUR) 1,360.63
Shares Outstanding (M) 33.90
30 Day Average Volume 223
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for C6O

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for C6O

Clovis Oncology Inc. is a biopharmaceutical company. The Company is focused on acquiring, developing and commercializing innovative anti-cancer agents in the United States, Europe and additional international markets. Clovis target its development programs for the treatment of specific subsets of cancer populations.

Patrick J MahaffyPresident/CEO/Co-FounderErle T MastExec VP/CFO/Secy/Co-Founder
Gillian C Ivers-ReadExec VP/Chief Regulatory OfcrAndrew R AllenExec VP/Chief Medical Ofcr
More Company Profile & Key Executives for C6O

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Links
sec ||= nil